388 related articles for article (PubMed ID: 23330786)
1. Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB.
Nagpal K; Singh SK; Mishra DN
Expert Opin Drug Deliv; 2013 Jul; 10(7):927-55. PubMed ID: 23330786
[TBL] [Abstract][Full Text] [Related]
2. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD
Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide.
Chacko AM; Li C; Pryma DA; Brem S; Coukos G; Muzykantov V
Expert Opin Drug Deliv; 2013 Jul; 10(7):907-26. PubMed ID: 23751126
[TBL] [Abstract][Full Text] [Related]
4. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.
Pardridge WM
Expert Opin Ther Targets; 2015; 19(8):1059-72. PubMed ID: 25936389
[TBL] [Abstract][Full Text] [Related]
6. Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles.
Patel M; Souto EB; Singh KK
Expert Opin Drug Deliv; 2013 Jul; 10(7):889-905. PubMed ID: 23550609
[TBL] [Abstract][Full Text] [Related]
7. Drug delivery to brain via the blood-brain barrier.
Scherrmann JM
Vascul Pharmacol; 2002 Jun; 38(6):349-54. PubMed ID: 12529929
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-mediated strategies in opening brain barriers for drug brain delivery.
Zhao YZ; Lu CT; Li XK; Cai J
Expert Opin Drug Deliv; 2013 Jul; 10(7):987-1001. PubMed ID: 23550691
[TBL] [Abstract][Full Text] [Related]
9. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption.
Al-Ahmady ZS
Expert Opin Drug Deliv; 2018 Apr; 15(4):335-349. PubMed ID: 29466890
[TBL] [Abstract][Full Text] [Related]
10. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
11. Vector-mediated drug delivery to the brain.
Temsamani J; Rousselle C; Rees AR; Scherrmann JM
Expert Opin Biol Ther; 2001 Sep; 1(5):773-82. PubMed ID: 11728213
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
[TBL] [Abstract][Full Text] [Related]
13. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
Gaillard PJ; de Boer AG
Methods Mol Biol; 2008; 437():161-75. PubMed ID: 18369968
[TBL] [Abstract][Full Text] [Related]
14. Liposomes for brain delivery.
Lai F; Fadda AM; Sinico C
Expert Opin Drug Deliv; 2013 Jul; 10(7):1003-22. PubMed ID: 23373728
[TBL] [Abstract][Full Text] [Related]
15. Modern methods for delivery of drugs across the blood-brain barrier.
Chen Y; Liu L
Adv Drug Deliv Rev; 2012 May; 64(7):640-65. PubMed ID: 22154620
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery across the blood-brain barrier using focused ultrasound.
Burgess A; Hynynen K
Expert Opin Drug Deliv; 2014 May; 11(5):711-21. PubMed ID: 24650132
[TBL] [Abstract][Full Text] [Related]
17. Advances in microphysiological blood-brain barrier (BBB) models towards drug delivery.
Lee CS; Leong KW
Curr Opin Biotechnol; 2020 Dec; 66():78-87. PubMed ID: 32711361
[TBL] [Abstract][Full Text] [Related]
18. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial approaches for the identification of brain drug delivery targets.
Stutz CC; Zhang X; Shusta EV
Curr Pharm Des; 2014; 20(10):1564-76. PubMed ID: 23789958
[TBL] [Abstract][Full Text] [Related]
20. Novel models for assessing blood-brain barrier drug permeation.
Geldenhuys WJ; Allen DD; Bloomquist JR
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):647-53. PubMed ID: 22468700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
